Bio-Techne Corp
NASDAQ:TECH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Bio-Techne Corp
Bio-Techne Corp
Accounts Receivables
Bio-Techne Corp
Accounts Receivables Peer Comparison
TMO
DHR
MTD
A
IQV
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio-Techne Corp
NASDAQ:TECH
|
Accounts Receivables
$227.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$9.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Receivables
$650.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Bio-Techne Corp's Accounts Receivables?
Accounts Receivables
227.9m
USD
Based on the financial report for Mar 31, 2024, Bio-Techne Corp's Accounts Receivables amounts to 227.9m USD.
What is Bio-Techne Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
17%
Over the last year, the Accounts Receivables growth was 5%. The average annual Accounts Receivables growth rates for Bio-Techne Corp have been 13% over the past three years , 11% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
